0001209191-23-034992.txt : 20230607 0001209191-23-034992.hdr.sgml : 20230607 20230607142947 ACCESSION NUMBER: 0001209191-23-034992 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230606 FILED AS OF DATE: 20230607 DATE AS OF CHANGE: 20230607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abbott Matthew S CENTRAL INDEX KEY: 0001786056 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 23998617 MAIL ADDRESS: STREET 1: C/O THE CHEMOURS COMPANY STREET 2: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-06-06 0 0001627223 Chemours Co CC 0001786056 Abbott Matthew S C/O THE CHEMOURS COMPANY 1007 MARKET STREET WILMINGTON DE 19801 0 1 0 0 SVP, Chief Enterprise Transfor Common Stock 29869.1243 D Stock Option (Right to Buy) 34.84 2033-03-01 Common Stock 4964 D Stock Option (Right to Buy) 25.98 2032-03-01 Common Stock 12740 D Stock Option (Right to Buy) 24.01 2031-03-01 Common Stock 12269 D Stock Option (Right to Buy) 14.43 2030-03-02 Common Stock 8912 D Stock Option (Right to Buy) 38.02 2029-03-01 Common Stock 6097 D Stock Option (Right to Buy) 48.53 2028-03-01 Common Stock 4136 D Stock Option (Right to Buy) 34.72 2027-03-01 Common Stock 5441 D Performance Stock Option (Right to Buy) 38.32 2033-03-01 Common Stock 5093 D Includes directly owned shares, restricted stock units and dividend equivalent units. Options vest in three equal installments beginning on March 1, 2024. Options vest in three equal installments beginning on March 1, 2023. Options vest in three equal installments beginning on March 1, 2022. Options are fully vested. Represents a 10 percent premium above the closing price of the Company common stock on the date of grant /s/ Pauletta Brown, Attorney-in-Fact 2023-06-07